S. 4480

S. 4480: A bill to direct the Secretary of Health and Human Services to issue guidance on coverage under the Medicaid program under title XIX of the Social Security Act of certain pelvic health services furnished during the postpartum period, and for oth

Introduced Lisa Blunt Rochester (D) SENATE_BILL — 119th Congress
Plain English Summary

S. 4480 is a bill that aims to instruct the Secretary of Health and Human Services to provide guidance on Medicaid coverage for specific pelvic health services that are offered during the postpartum period. This bill focuses on ensuring that women receive necessary pelvic health care after childbirth under the Medicaid program.

Positive Media Summary

Supporters of S. 4480 have praised the bill for addressing an important aspect of women's health care that is often overlooked. Many advocates believe that improving access to pelvic health services postpartum will lead to better health outcomes for mothers and help reduce long-term health issues related to childbirth.

Negative Media Summary

Critics of S. 4480 argue that the bill may not go far enough in ensuring comprehensive coverage for all necessary postpartum health services. Some have expressed concerns that merely issuing guidance may not translate into effective policy changes, and that more robust legislative action is needed to fully support women's health in the postpartum period.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

The analysis of bill S. 4480, which pertains to Medicaid coverage for pelvic health services during the postpartum period, shows no direct industry overlaps with the sponsor Lisa Blunt Rochester's top donor industries. While there is lobbying activity in the policy area, the disclosed amounts are either undisclosed or minimal, with only DIRSHU INTERNATIONAL reporting a contribution of $100,000 through MERKAVA STRATEGIES CORPORATION. This suggests that while there is some interest from lobbying entities, the financial ties do not directly correlate with the bill's subject matter, indicating a low risk of conflict of interest. Voters should be aware that while lobbying exists, it does not appear to significantly influence the legislative intent of the bill based on the available data.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
DIRSHU INTERNATIONAL MERKAVA STRATEGIES CORPORATION $100,000
CEO WORKS SAUNDERS GLOBAL DIPLOMACY $45,000
KAZI IG SAUNDERS GLOBAL DIPLOMACY $15,000
SOUTHERN FOLGER CONTRACTING BBT STRATEGIES LLC $10,000
WATERFRONT GLOBAL BBT STRATEGIES LLC $5,200
DIGITALEUROPE VIVID STRATEGIES LLC undisclosed
INTERNATIONAL CHRISTIAN CHAMBER OF COMMERCE MERKAVA STRATEGIES CORPORATION undisclosed
DR. STEPHEN SOLOWAY MERKAVA STRATEGIES CORPORATION undisclosed
ONE ISRAEL FUND MERKAVA STRATEGIES CORPORATION undisclosed
HEMOGLOBIN OXYGEN THERAPEUTICS MERKAVA STRATEGIES CORPORATION undisclosed
ATAOLLAH AMINPOUR MERKAVA STRATEGIES CORPORATION undisclosed
HERSEL NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MORAD BEN NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MARK SCOTT MERKAVA STRATEGIES CORPORATION undisclosed
BORIS MINTS MERKAVA STRATEGIES CORPORATION undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Lisa Blunt Rochester, ranked by total contributions.

Health Professionals $120,000,000
Individuals: $120,000,000 PACs: $0
Retired $37,500,000
Individuals: $37,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us